The No. 1 New Year’s resolution isn’t losing weight or exercising — it’s this financial goal, surveys say
Wealth is topping health among many people’s 2025 goals. Here’s how to stick to your financial resolutions.
Wealth is topping health among many people’s 2025 goals. Here’s how to stick to your financial resolutions.
Bond yields inch up on Tuesday ahead of retail sales data.
Bridgewater Associates, the world’s hedge fund by assets under management, says the impact on bond yields depends not just on the government deficit but that of private-sector companies as well.
Satya Nadella, Microsoft’s CEO, and believed to be a big customer of Nvidia was talking about abundant chip supply in a recent interview.
“We have been bringing in $60,000 a year for the last couple years, until this October, when I was laid off.”
Where will Swift head to spend some well-deserved R&R in her post-Eras era? She has some amazing real estate to choose from.
The basketball star inked a 4-year deal with a base salary for 2024 of just $76,535, a low sum compared with her male counterparts in the NBA.
Injuries at Amazon.com Inc.’s warehouses are more common than in other warehouses, a new government report alleged over the weekend, claiming that the online-retail giant manipulated injury data and ignored recommendations to keep workers safer as it pursued speed and profits.
Current rates are significantly contractionary
Shares of the online retailer of pet products ended Monday’s session up 4%, registering their largest percent increase since Nov. 20.
Drone sightings have become a big issue in the past week. Here are five things to know about it.
Disney’s earnings forecasts once struck analysts as aggressive, but now they veer toward “believability,” according to an analyst.
Deutsche Bank Research chart shows the top market risks cited by investors versus a year ago.
China’s latest restrictions mark “several firsts in the trade war,” researchers say.
Investors might be well served by expanding beyond the S&P 500.
Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance of GLP agonists in 2025, Barclays analysts said
One analyst is “very bullish” on Micron’s stock ahead of what could be a mixed report on Wednesday. But he cautioned that a post-earnings stock bump might not last long.
S&P services survey shows business is booming
The newest member of the trillion-dollar market-cap club is looking ahead to a “likely sharp new product ramp” in the second half of 2025, according to an analyst.
Yields on U.S. government debt dropped from their highest levels in a few weeks on Monday as buyers emerged during the Asian, European and early U.S. sessions.